Angie Purvis brings a wealth of experience leading diagnostic products to market by successfully combining her broad scientific and product development skills and her regulatory expertise to create high-quality in vitro diagnostics and laboratory-based diagnostics. She is a Board-certified Laboratory Director with over 15 years of experience directing high-complexity molecular, immunological, and clinical chemistry laboratories that develop and perform laboratory developed tests (LDT). She has worked with companies of all sizes to build or improve quality management systems that are compliant with ISO13485 and 21 CFR 820. Angie has extensive experience navigating complex regulatory pathways for medical products in the USA, EU, and developing/emerging markets and has a strong track record in diagnostic tests for infectious disease and oncology. Angie received her BS in Biology from Centre College. She earned a PhD in Biochemistry from Washington University, Department of Medicine, Division of Hematology and Oncology and completed a postdoctoral fellowship at Washington University, Howard Hughes Medical Institute in proteomics.